Cargando…
MiR-29c-3p inhibits epithelial-mesenchymal transition to inhibit the proliferation, invasion and metastasis of cervical cancer cells by targeting SPARC
BACKGROUND: Cervical cancer is one of the most common gynecological malignancies. Cancer recurrence and the poor efficacy of cervical cancer treatments are mainly caused by invasion and metastasis of cervical cancer cells. This study is to investigate whether miR-29c-3p can inhibit epithelial-mesenc...
Autores principales: | Zou, Ting, Gao, Yan, Qie, Mingrong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7867928/ https://www.ncbi.nlm.nih.gov/pubmed/33569427 http://dx.doi.org/10.21037/atm-20-7272 |
Ejemplares similares
-
miR-211 inhibits proliferation, invasion and migration of cervical cancer via targeting SPARC
por: Qu, Xuqin, et al.
Publicado: (2018) -
miR-29a-3p regulates the epithelial-mesenchymal transition via the SPARC/ERK signaling pathway in human bronchial epithelial cells
por: Zhang, Xiaobo, et al.
Publicado: (2021) -
miR-573 inhibits prostate cancer metastasis by regulating epithelial-mesenchymal transition
por: Wang, Lin, et al.
Publicado: (2015) -
miR-300 inhibits epithelial to mesenchymal transition and metastasis by targeting Twist in human epithelial cancer
por: Yu, Jingshuang, et al.
Publicado: (2014) -
MiR-195 suppresses the metastasis and epithelial–mesenchymal transition of hepatocellular carcinoma by inhibiting YAP
por: Yu, Shuo, et al.
Publicado: (2017)